Citigroup
MIRA icon

Citigroup’s MIRA Pharmaceuticals MIRA Stock Holding History

Citigroup’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14K Sell
1,207
-3,019
-71% -$3.05K ﹤0.01% 5402
2026
Q1 		$4.52K Buy
+4,226
New +$5.3K ﹤0.01% 5286
2025
Q4 		– Sell
-3,820
Closed -$5.2K – 6302
2025
Q3 		$5.2K Buy
+3,820
New +$5.54K ﹤0.01% 5219

Other funds holding MIRA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Citigroup's MIRA Position: Q2 2026 in Review

Citigroup reduced its MIRA Pharmaceuticals (MIRA) stake by 71% in Q2 2026, selling an estimated $3.05K and leaving 1,207 shares worth $1.14K. The position accounts for ﹤0.01% of the portfolio, ranked #5402.

Citigroup first reported a position in MIRA in Q3 2025 and has held it in 3 quarters since. The position peaked at $5.2K in Q3 2025. 26 funds tracked by Wall St. Rank hold MIRA as of Q2 2026.

  • Citigroup held 1,207 shares of MIRA Pharmaceuticals worth $1.14K as of Q2 2026.
  • Citigroup sold 3,019 MIRA Pharmaceuticals shares in Q2 2026, an estimated $3.05K.
  • MIRA Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5402 holding.
  • Citigroup first reported a position in MIRA Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Citigroup's MIRA Pharmaceuticals position peaked at $5.2K in Q3 2025.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.